Tesamorelin/Ipamorelin

FDA APPROVAL PENDING

Tesamorelin/Ipamorelin

GHRH + GHS Dual-Pathway Blend | Fat Loss & GH Optimization

Learn more

Growth

Tesamorelin/Ipamorelin

Metabolic

Amino acid sequence

35

Amino acids

5135.9da

Molecular weight

Blend

Type

Tesamorelin/Ipamorelin is a synergistic peptide blend combining a GHRH analogue (Tesamorelin) with a selective ghrelin mimetic (Ipamorelin) to amplify endogenous growth hormone release through two distinct receptor pathways. Tesamorelin is FDA-approved (EGRIFTA) for HIV-associated lipodystrophy and has demonstrated 15–17.5% visceral fat reduction in clinical trials; Ipamorelin adds pulsatile GH stimulation without elevating cortisol or prolactin. The stack is used in clinical and functional medicine settings for body recomposition, metabolic improvement, and anti-aging hormone optimization.

Top researched benefits

Overview of Tesamorelin/Ipamorelin

Tesamorelin binds pituitary GHRH receptors to restore physiologic GH pulses and raise IGF-1, while Ipamorelin activates ghrelin/GHS-R1a receptors to initiate a separate GH pulse at the somatotroph. The dual-pathway stimulation produces a synergistic GH response greater than either compound alone, as the GHRP-initiated pulse is amplified by simultaneous GHRH-receptor activation.

body composition

  • Tesamorelin has demonstrated fat reduction in clinical trials; synergy with Ipamorelin may enhance effects.
  • Tesamorelin specifically reduces visceral adipose tissue (FDA-approved indication).
  • Enhanced GH promotes protein synthesis and lean tissue preservation.

recovery and wellness

  • GH secretagogues often improve deep sleep quality.
  • Enhanced GH supports tissue repair and recovery from exercise.
  • Restoring more youthful GH levels may provide anti-aging benefits.

metabolic health

  • Tesamorelin has shown improvements in lipid parameters in studies.
  • Increased GH leads to increased IGF-1 production.

Typical Dose

300mcg Tesamorelin + 100mcg Ipamorelin per injection

Frequency

twice daily (morning and evening, fasted)

Cycle Duration

8 weeks on, 8 weeks off; 5 days on, 2 days off weekly

Storage

Lyophilized powder: store at -20°C (up to 18–24 months) or 2–8°C. Reconstituted with bacteriostatic water: refrigerate at 2–8°C, protected from light, use within 28 days. Do not freeze reconstituted solution.

Chemical Makeup

Key benefits

Reduces visceral adipose tissue by approximately 15–17.5% over 26–52 weeks, with clinical trial data showing superiority over placebo in HIV lipodystrophy populations

Increases lean body mass by approximately 1.42 kg through sustained elevation of GH and IGF-1 without exogenous GH administration

Ipamorelin selectively stimulates GH release without significantly raising cortisol, ACTH, or prolactin, making the combination suitable for longer cycles compared to non-selective GHRPs

Dual-pathway GH stimulation mimics the natural youthful pulsatile rhythm of GH secretion, producing a synergistic GH release greater than either compound used alone

Community interest

This peptide is still gaining traction in the community.

GHRH + GHS Dual-Pathway Blend | Fat Loss & GH Optimization

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Tesamorelin/Ipamorelin Molecular Information

View the scientifc details of Tesamorelin/Ipamorelin .

35

Amino Acids

Tesamorelin/Ipamorelin

Thr

Thr

Position 1

Glu

Glu

Position 2

Ser

Ser

Position 3

Ala

Ala

Position 4

Met

Met

Position 5

Pyl

Pyl

Position 6

Arg

Arg

Position 7

Glu

Glu

Position 8

Leu

Leu

Position 9

Ile

Ile

Position 10

Asn

Asn

Position 11

Gly

Gly

Position 12

His

His

Position 13

Arg

Arg

Position 14

His

His

Position 15

Ala

Ala

Position 16

Asn

Asn

Position 17

Ala

Ala

Position 18

Leu

Leu

Position 19

Pyl

Pyl

Position 20

Gly

Gly

Position 21

Ile

Ile

Position 22

Pro

Pro

Position 23

Ala

Ala

Position 24

Met

Met

Position 25

Pyl

Pyl

Position 26

Arg

Arg

Position 27

Glu

Glu

Position 28

Leu

Leu

Position 29

Ile

Ile

Position 30

Asn

Asn

Position 31

Gly

Gly

Position 32

His

His

Position 33

Arg

Arg

Position 34

Pro

Pro

Position 35

Amino acid sequence
ThreoninePosition 1
Glutamic acidPosition 2
SerinePosition 3
AlaninePosition 4
MethioninePosition 5
PyrrolysinePosition 6
ArgininePosition 7
Glutamic acidPosition 8
LeucinePosition 9
IsoleucinePosition 10
AsparaginePosition 11
GlycinePosition 12
HistidinePosition 13
ArgininePosition 14
HistidinePosition 15
AlaninePosition 16
AsparaginePosition 17
AlaninePosition 18
LeucinePosition 19
PyrrolysinePosition 20
GlycinePosition 21
IsoleucinePosition 22
ProlinePosition 23
AlaninePosition 24
MethioninePosition 25
PyrrolysinePosition 26
ArgininePosition 27
Glutamic acidPosition 28
LeucinePosition 29
IsoleucinePosition 30
AsparaginePosition 31
GlycinePosition 32
HistidinePosition 33
ArgininePosition 34
ProlinePosition 35

Molecular Weight

5135.9Da

Chain Length

35Amino Acids

Type

Blend

Tesamorelin/Ipamorelin Protocols

Subcutaneous injection into the lower abdomen is the only clinically documented route for the Tesamorelin/Ipamorelin blend. The combination is administered fasted at least 2–3 hours after the last meal — ideally 30–90 minutes before sleep — to amplify the natural nocturnal GH pulse through dual GHRH/ghrelin-mimetic pathway activation.

GoalDosageFrequencyRoute
Visceral fat reduction — entry dose0.3751 day rangeSubQ abdomen
Visceral fat reduction — titration mid0.751 day rangeSubQ abdomen
Body composition and lean mass1.51 day rangeSubQ abdomen
GH optimization and anti-aging2.251 day rangeSubQ abdomen
Advanced body recomposition — full dose31 day rangeSubQ abdomen
Sleep quality and recovery — female low dose0.21 day rangeSubQ abdomen

Reconstitution Instructions

Materials needed:

Insulin syringes (0.5–1 mL, 29–31 gauge)3 mL drawing syringe with 18–21 gauge needle (for reconstitution)Bacteriostatic water (3 mL per 10 mg blend vial)Alcohol swabsSterile gauze padsSharps disposal container

Steps to reconstitute

  1. Remove the blend vial from the refrigerator and allow it to reach room temperature for 5–10 minutes before reconstitution
  2. Wipe the rubber stopper of both the peptide vial and the bacteriostatic water vial with a fresh alcohol swab and allow to air dry for 30 seconds
  3. Draw 3.0 mL of bacteriostatic water into a 3 mL syringe with an 18–21 gauge needle — this yields approximately 3.33 mg/mL total (1.67 mg/mL each peptide) in a 10 mg blend vial
  4. Insert the syringe needle through the stopper at an angle and inject the bacteriostatic water slowly down the inner glass wall of the vial — never shoot it directly onto the powder
  5. Remove the syringe and gently swirl or roll the vial between your palms for 30–60 seconds until the powder fully dissolves — do not shake
  6. Inspect the reconstituted solution — it should be clear and colorless with no visible particles; discard if cloudy or particulate
  7. Using a fresh insulin syringe, draw the calculated dose volume from the reconstituted vial and expel any air bubbles
  8. Pinch a fold of skin at the lower abdomen at least 2 inches from the navel, insert the needle at 90 degrees (or 45 degrees if lean), inject slowly, then remove and apply light pressure with a gauze pad
  9. Rotate injection sites systematically — left abdomen, right abdomen, outer thighs, upper arms — to prevent lipohypertrophy
  10. Cap the used syringe and dispose in a sharps container; return the reconstituted vial to the refrigerator and use within 28 days

Tesamorelin/Ipamorelin Cycle

The Tesamorelin/Ipamorelin Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Improved sleep quality often noticed first; initial GH response
Week 2-4
Enhanced recovery; subtle body composition changes beginning
Week 4-8
Noticeable fat loss (especially visceral); improved energy
Week 8-16
Full body composition benefits; continued improvements

Dosing tools

Tesamorelin/Ipamorelin Blend Dosage Calculator

Calculate blended peptide doses with our visual syringe guide.

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

1 mL

2 mL

3 mL

5 mL

Custom

Blend Composition

Total: 10.0 mg

mg

mg

The compound you want to dose by. Results will be calculated based on this compound.

The dose of the anchor compound you want per administration, in mcg or mg.

Conversion: 1,000 mcg = 1 mg

Results

Concentration

10.00

mg/mL

Doses per vial

20

Total blend to inject

0.50

mg

You'll get:

Ipamorelin
250 mcgANCHOR
Tesamorelin
250 mcg

1mL / 100 units

5 units

0.050 mL

Dosing Guidance

Recommended Schedule

twice daily (morning and evening, fasted)

Supply Duration

This vial provides 20 doses (20-day supply at 250 mcg daily)

Peptide Interactions

Research suggestions of Tesamorelin/Ipamorelin interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

COMPATIBLE

Different mechanisms; can complement for healing with GH support.

COMPATIBLE

Weight

mk6

Growth

MK-677

MONITOR

Both affect GH release; combination may be excessive and affect glucose.

MONITOR

Weight

GLP-1

Metabolic

GLP-1

COMPATIBLE

Different pathways; some combine for body composition goals.

COMPATIBLE

Side effects

Monitor: Be careful when combining Tesamorelin/Ipamorelin with MK-677.

Contraindications

Active malignancy (GH may promote tumor growth)

Diabetic retinopathy

Pregnancy or breastfeeding

Pituitary disorders

Hypersensitivity to components

Stop signs

Severe injection site reactions

Significant swelling or edema

Signs of glucose dysregulation

Severe joint pain

Allergic reactions

Bad signs

No Certificate of AnalysisCannot verify Tesamorelin:Ipamorelin ratioDiscolored or particulate solution
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

Tesamorelin/Ipamorelin Research References

Tesamorelin/Ipamorelin is a phase 3 compound

4Research references

Tesamorelin/Ipamorelin

Tesamorelin/Ipamorelin is a phase 3 compound

Tesamorelin FDA Approval for HIV Lipodystrophy

Tesamorelin (Egrifta) approved for reduction of excess abdominal fat in HIV patients.

n.d.

Tesamorelin Effects on Visceral Fat

Tesamorelin significantly reduces visceral adipose tissue and improves lipid profiles.

n.d.

Ipamorelin Selectivity Profile

Ipamorelin selectively releases GH without affecting cortisol, prolactin, or ACTH.

n.d.

GHRH + GHRP Synergy

Combining GHRH and GHRP pathways produces synergistic GH release greater than either alone.

n.d.

Calculate peptide dosages

Learning how to calculate a peptide dose? Use our beginner-friendly peptide dosage, blend, and accumulation calculators. Enter vial size, reconstitution volume, and target dose to get exact draw volumes instantly. No guesswork, just clear guidance that helps prevent common mistakes.